Insmed INSM
NASDAQ INSM
$111.12 +2.53 (+2.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Insmed (INSM) Other Accumulated Expenses (2011 - 2026)

Updated

Insmed (INSM) posted Other Accumulated Expenses of $37.77 million for Q2 2026, up 362.8% from $8.16 million a year earlier and up 62.2% from the prior quarter.

Analysis

Insmed (INSM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2025, Insmed's Other Accumulated Expenses came in at $17.1 million, up 170.4% from FY2024.

  • Annual Other Accumulated Expenses has increased for three consecutive years, with a four-year compound annual growth rate of 26.6% (FY2021 to FY2025).
  • In prior years, Insmed's Other Accumulated Expenses was $6.32 million in FY2024 (+11.5%), $5.67 million in FY2023 (+20.5%), $4.71 million in FY2022 (-29.2%) and $6.66 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2011.
  • On a year-over-year basis, Other Accumulated Expenses has increased in each of the last four quarters, with growth averaging 89.0% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2026, with growth of 362.8%; the weakest was Q4 2022, with a decline of 29.2%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $23.29 million (Q1 2026), $17.1 million (Q4 2025) and $9.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Insmed 24.26 Bn 18.76 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.77 Mn
Mar 31, 2026 23.29 Mn
Dec 31, 2025 17.10 Mn
Sep 30, 2025 9.37 Mn
Jun 30, 2025 8.16 Mn
Mar 31, 2025 10.94 Mn
Dec 31, 2024 6.32 Mn
Sep 30, 2024 8.53 Mn
Jun 30, 2024 8.65 Mn
Mar 31, 2024 10.21 Mn
Dec 31, 2023 5.67 Mn
Sep 30, 2023 5.98 Mn
Jun 30, 2023 6.23 Mn
Mar 31, 2023 6.17 Mn
Dec 31, 2022 4.71 Mn
Sep 30, 2022 5.32 Mn
Dec 31, 2021 6.66 Mn
Mar 31, 2020 78,000.00
Dec 31, 2019 280,000.00
Sep 30, 2019 130,000.00
API Access

Insmed Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INSM&period=max&api_key=YOUR_API_KEY